J3391 Injection, atidarsagene autotemcel
J-Codes
Also known as: atidarsagene autotemcel, Zynyz, gene therapy
Atidarsagene autotemcel (Zynyz) injection is a genetically modified autologous T cell therapy for severe combined immunodeficiency treatment.
Clinical Context
Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency. Autologous T cells modified ex vivo with a functional adenosine deaminase gene. Intravenous administration for immune reconstitution.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.